Generic warfarin: Implications for patient care - Another view

被引：0
作者：
Meyer, M
Chan, K
Bolton, S
机构：
[1] Univ Tennessee, Coll Pharm, Memphis, TN 38163 USA
[2] Univ Arizona, Coll Pharm, Tucson, AZ 85721 USA
[3] Globomax, Hanover, NH USA
来源：
PHARMACOTHERAPY | 1998年 / 18卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：884 / 886
页数：3
相关论文
共 7 条
[1]   Flawed statistical analyses and representations of fact [J].
Bolton, S .
DRUG DEVELOPMENT AND INDUSTRIAL PHARMACY, 1997, 23 (08) :851-853
[2]  
HENRY MB, 1997, COMMUNICATION
[3]  
NEUTEL JM, 1998, CARDIOVASC REV REP, V19, P49
[4]   MEDICAL AND ECONOMIC CONSEQUENCES OF A BLINDED ORAL ANTICOAGULANT BRAND CHANGE AT A MUNICIPAL HOSPITAL [J].
RICHTONHEWETT, S ;
FOSTER, E ;
APSTEIN, CS .
ARCHIVES OF INTERNAL MEDICINE, 1988, 148 (04) :806-808
[5]  
RUEDY J, 1976, CAN MED ASSOC J, V115, P105
[6]   IN-VIVO AND IN-VITRO AVAILABILITY OF COMMERCIAL WARFARIN TABLETS [J].
WAGNER, JG ;
WELLING, PG ;
LEE, KP ;
WALKER, JE .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1971, 60 (05) :666-&
[7]  
Wittkowsky AK, 1997, PHARMACOTHERAPY, V17, P640
1